Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease.

A spectrum of disease severity has been observed in patients with Lyme disease, with approximately 60% of untreated individuals developing arthritis. The murine model of Lyme disease has provided strong evidence that the genetic composition of the host influences the severity of arthritis following infection with Borrelia burgdorferi: infected C3H mice develop severe arthritis while infected C57BL/6N mice develop mild arthritis. Regions of the mouse genome controlling arthritis severity and humoral responses during B. burgdorferi infection were identified in the F2 intercross generation of C3H/HeNCr and C57BL/6NCr mice. Rear ankle swelling measurements identified quantitative trait loci (QTL) on chromosomes 4 and 5, while histopathological scoring identified QTL on a unique region of chromosome 5 and on chromosome 11. The identification of QTL unique for ankle swelling or histopathological severity suggests that processes under distinct genetic control are responsible for these two manifestations of Lyme arthritis. Additional QTL that control the levels of circulating Igs induced by B. burgdorferi infection were identified on chromosomes 6, 9, 11, 12, and 17. Interestingly, the magnitude of the humoral response was not correlated with the severity of arthritis in infected F2 mice. This work defines several genetic loci that regulate either the severity of arthritis or the magnitude of humoral responses to B. burgdorferi infection in mice, with implications toward understanding the host-pathogen interactions involved in disease development.

[1]  J. Todd,et al.  New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. , 1998, Journal of immunology.

[2]  R. Doerge,et al.  Autoimmune orchitis, epididymitis, and vasitis are immunogenetically distinct lesions. , 1998, The American journal of pathology.

[3]  C. Teuscher,et al.  Distinct Characteristics of Resistance toBorrelia burgdorferi-Induced Arthritis in C57BL/6N Mice , 1998, Infection and Immunity.

[4]  E. Fikrig,et al.  Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. , 1997, Journal of immunology.

[5]  E. Fikrig,et al.  Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice , 1997, Infection and immunity.

[6]  E. Fikrig,et al.  Borrelia burgdorferi P35 and P37 proteins, expressed in vivo, elicit protective immunity. , 1997, Immunity.

[7]  P. Pennington,et al.  Arthritis severity and spirochete burden are determined by serotype in the Borrelia turicatae-mouse model of Lyme disease , 1997, Infection and immunity.

[8]  M. Daly,et al.  Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Harrich,et al.  Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B , 1996, Infection and immunity.

[10]  J. Radolf,et al.  Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro , 1996, Infection and immunity.

[11]  F. Finkelman,et al.  Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. , 1996, Journal of immunology.

[12]  M. Philipp,et al.  Molecular characterization, genomic arrangement, and expression of bmpD, a new member of the bmp class of genes encoding membrane proteins of Borrelia burgdorferi , 1996, Infection and immunity.

[13]  E. Fikrig,et al.  Effect of anti-interleukin 12 treatment on murine lyme borreliosis. , 1996, The Journal of clinical investigation.

[14]  W. Golde,et al.  Variation in antigenicity and infectivity of derivatives of Borrelia burgdorferi, strain B31, maintained in the natural, zoonotic cycle compared with maintenance in culture , 1995, Infection and immunity.

[15]  J. Radolf,et al.  Evidence for in vivo but not in vitro expression of a Borrelia burgdorferi outer surface protein F (OspF) homologue , 1995, Molecular microbiology.

[16]  J. Weis,et al.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology , 1995, Infection and immunity.

[17]  A. Keane-Myers,et al.  Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. , 1995, Journal of immunology.

[18]  E. Fikrig,et al.  Borrelia burgdorferi genes selectively expressed in the infected host. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Reiner,et al.  T helper phenotype and genetic susceptibility in experimental Lyme disease , 1995, The Journal of experimental medicine.

[20]  S. Telford,et al.  Early murine Lyme carditis has a macrophage predominance and is independent of major histocompatibility complex class II-CD4+ T cell interactions. , 1995, The Journal of infectious diseases.

[21]  R. Doerge,et al.  Empirical threshold values for quantitative trait mapping. , 1994, Genetics.

[22]  M. Woods,et al.  Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway , 1994, Infection and immunity.

[23]  Z. Zeng.  Precision mapping of quantitative trait loci. , 1994, Genetics.

[24]  D. Persing,et al.  Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues , 1994 .

[25]  A. Steere,et al.  Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. , 1994, The New England journal of medicine.

[26]  Z B Zeng,et al.  Theoretical basis for separation of multiple linked gene effects in mapping quantitative trait loci. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Weis,et al.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties , 1993, Infection and immunity.

[28]  A. Steere,et al.  Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi , 1993, Infection and immunity.

[29]  D. Fish,et al.  The biological and social phenomenon of Lyme disease. , 1993, Science.

[30]  T. Burkot,et al.  The major histocompatibility complex-restricted response of recombinant inbred strains of mice to natural tick transmission of Borrelia burgdorferi , 1993, The Journal of experimental medicine.

[31]  S. Barthold,et al.  Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. , 1992, The American journal of tropical medicine and hygiene.

[32]  J. Weis,et al.  Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice , 1992, Infection and immunity.

[33]  E S Lander,et al.  A genetic map of the mouse suitable for typing intraspecific crosses. , 1992, Genetics.

[34]  D. Persing,et al.  Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. , 1991, The American journal of pathology.

[35]  Jean Côté,et al.  Lyme Disease , 1991, International journal of dermatology.

[36]  Soumitra Ghosh,et al.  Genetic analysis of autoimmune type 1 diabetes mellitus in mice , 1991, Nature.

[37]  U. Schaible,et al.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver. , 1990, The American journal of pathology.

[38]  J. Love,et al.  Towards construction of a high resolution map of the mouse genome using PCR-analysed microsatellites. , 1990, Nucleic acids research.

[39]  S. Barthold,et al.  Lyme borreliosis in selected strains and ages of laboratory mice. , 1990, The Journal of infectious diseases.

[40]  L. Sigal,et al.  Lyme disease, 1988: immunologic manifestations and possible immunopathogenetic mechanisms. , 1989, Seminars in arthritis and rheumatism.

[41]  Eric S. Lander,et al.  Resolution of quantitative traits into Mendelian factors by using a complete linkage map of restriction fragment length polymorphisms , 1988, Nature.

[42]  A. Steere,et al.  In vivo and in vitro evidence of B cell hyperactivity during Lyme disease. , 1988, The Journal of rheumatology.

[43]  M. Daly,et al.  MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. , 1987, Genomics.

[44]  J. P. Davis,et al.  Lyme disease: A tick-borne spirochetosis , 1983 .

[45]  C. Wittwer,et al.  Continuous fluorescence monitoring of rapid cycle DNA amplification. , 1997, BioTechniques.

[46]  L. Sigal.  Lyme disease: a review of aspects of its immunology and immunopathogenesis. , 1997, Annual review of immunology.

[47]  D. Persing,et al.  Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. , 1994, Infection and immunity.

[48]  E. Lander,et al.  Mendelian factors underlying quantitative traits in tomato: comparison across species, generations, and environments. , 1991, Genetics.